JP2019523233A5 - - Google Patents

Download PDF

Info

Publication number
JP2019523233A5
JP2019523233A5 JP2018566971A JP2018566971A JP2019523233A5 JP 2019523233 A5 JP2019523233 A5 JP 2019523233A5 JP 2018566971 A JP2018566971 A JP 2018566971A JP 2018566971 A JP2018566971 A JP 2018566971A JP 2019523233 A5 JP2019523233 A5 JP 2019523233A5
Authority
JP
Japan
Prior art keywords
thieno
methyl
pyridazin
dimethyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018566971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019523233A (ja
JP7038414B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/038711 external-priority patent/WO2017223290A1/en
Publication of JP2019523233A publication Critical patent/JP2019523233A/ja
Publication of JP2019523233A5 publication Critical patent/JP2019523233A5/ja
Application granted granted Critical
Publication of JP7038414B2 publication Critical patent/JP7038414B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018566971A 2016-06-22 2017-06-22 ムスカリン性アセチルコリンレセプターm4のポジティブアロステリック調節因子 Active JP7038414B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662353447P 2016-06-22 2016-06-22
US62/353,447 2016-06-22
US201662418638P 2016-11-07 2016-11-07
US62/418,638 2016-11-07
US201762471281P 2017-03-14 2017-03-14
US62/471,281 2017-03-14
PCT/US2017/038711 WO2017223290A1 (en) 2016-06-22 2017-06-22 Positive allosteric modulators of the muscarinic acetylcholine receptor m4

Publications (3)

Publication Number Publication Date
JP2019523233A JP2019523233A (ja) 2019-08-22
JP2019523233A5 true JP2019523233A5 (enExample) 2020-07-30
JP7038414B2 JP7038414B2 (ja) 2022-03-18

Family

ID=60675830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018566971A Active JP7038414B2 (ja) 2016-06-22 2017-06-22 ムスカリン性アセチルコリンレセプターm4のポジティブアロステリック調節因子

Country Status (30)

Country Link
US (5) US10239887B2 (enExample)
EP (2) EP3474846B1 (enExample)
JP (1) JP7038414B2 (enExample)
KR (1) KR102474326B1 (enExample)
CN (2) CN116178391A (enExample)
AU (1) AU2017281228B2 (enExample)
BR (1) BR112018003417B1 (enExample)
CL (1) CL2018003669A1 (enExample)
CO (1) CO2018013600A2 (enExample)
CR (1) CR20180598A (enExample)
DK (1) DK3474846T3 (enExample)
DO (1) DOP2018000263A (enExample)
EC (1) ECSP18094769A (enExample)
ES (1) ES2936827T3 (enExample)
FI (1) FI3474846T3 (enExample)
GE (2) GEAP202014954A (enExample)
IL (1) IL263500B (enExample)
JO (1) JOP20180114B1 (enExample)
MA (1) MA45463A (enExample)
MX (1) MX385384B (enExample)
NI (1) NI201800141A (enExample)
PE (1) PE20190446A1 (enExample)
PH (1) PH12018502638B1 (enExample)
RU (1) RU2750935C2 (enExample)
SG (1) SG11201810794VA (enExample)
SV (1) SV2018005800A (enExample)
TN (1) TN2018000416A1 (enExample)
UA (1) UA125874C2 (enExample)
WO (1) WO2017223290A1 (enExample)
ZA (1) ZA201808219B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017107089A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor
ES2789756T3 (es) 2015-12-23 2020-10-26 Merck Sharp & Dohme Moduladores alostéricos de 6,7-dihidro-5H-pirrolo[3,4-b]piridin-5-ona del receptor de acetilcolina muscarínico M4
BR112018003417B1 (pt) * 2016-06-22 2023-10-24 Vanderbilt University Composto modulador alostérico positivo do receptor muscarínico de acetilcolina m4 e composição farmacêutica que o compreende
US10927126B2 (en) 2016-11-07 2021-02-23 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
US11008335B2 (en) 2016-11-07 2021-05-18 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
CN109862893B (zh) * 2016-11-07 2023-02-17 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112840A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112842A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor
WO2019000237A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000236A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000238A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
AU2018300980A1 (en) 2017-07-12 2020-01-02 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
ES3064093T3 (en) 2017-10-20 2026-04-22 Univ Vanderbilt Antagonists of the muscarinic acetylcholine receptor m4
TW201930311A (zh) 2017-12-05 2019-08-01 泛德比爾特大學 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑
JP2021505581A (ja) 2017-12-05 2021-02-18 ヴァンダービルト ユニヴァーシティ ムスカリン性アセチルコリンレセプターm4のポジティブアロステリック調節因子
CN110950774B (zh) * 2019-11-04 2021-04-13 北京大学 蛋白质定量标记试剂及其制备方法与应用
TW202134231A (zh) 2019-12-06 2021-09-16 美商紐羅克里生物科學有限公司 蕈毒受體4拮抗劑及使用方法
JP7707176B2 (ja) * 2020-02-05 2025-07-14 ニューロクライン バイオサイエンシーズ,インコーポレイテッド ムスカリン性受容体4アンタゴニストおよび使用方法
CN116669737A (zh) * 2020-12-22 2023-08-29 范德堡大学 毒蕈碱型乙酰胆碱受体m4的拮抗剂
US20250302831A1 (en) * 2021-04-20 2025-10-02 The Regents Of The University Of California Therapy for alcohol-related liver disease
WO2023114224A1 (en) 2021-12-13 2023-06-22 Sage Therapeutics, Inc. Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators
WO2025129082A1 (en) * 2023-12-14 2025-06-19 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m4

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594001A (en) 1993-04-08 1997-01-14 The Dupont Merck Pharmaceutical Company Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
AU2001231154A1 (en) * 2000-01-24 2001-07-31 Adherex Technologies Inc. Peptidomimetic modulators of cell adhesion
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US20020123485A1 (en) * 2000-07-27 2002-09-05 Alexander John C. Epoxy steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
US7291733B2 (en) * 2003-10-10 2007-11-06 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted tricyclic heterocycles and their uses
US20090099165A1 (en) * 2003-10-14 2009-04-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
ES2344007T3 (es) * 2003-10-14 2010-08-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Inhibidores proteina quinasa.
AR049300A1 (es) 2004-06-15 2006-07-12 Schering Corp Compuestos triciclicos antagonistas de mglur1 como agentes terapeuticos
EP1619196A1 (de) 2004-07-23 2006-01-25 Curacyte Discovery GmbH Substituierte Pyrido[3',2':4,5]thieno[3,2-d]pyrimidine und Pyrido[3',2':4,5]furo[3,2-d]-pyrimidine zur Verwendung als Inhibitoren der PDA-4 und/oder TNF-alpha Freisetzung
WO2006010567A1 (de) 2004-07-23 2006-02-02 Curacyte Discovery Gmbh INHIBITOREN DER PHOSPHODIESTERASE 4 UND TNFα-FREISETZUNG
MX2007004794A (es) 2004-10-25 2007-07-09 Lilly Co Eli Tienopiridinas como potenciadores alostericos del receptor muscarinico m4.
ES2259891B1 (es) 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259892B1 (es) 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
WO2006138418A2 (en) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
AR059901A1 (es) 2006-03-20 2008-05-07 Bayer Pharmaceuticals Corp Compuestos de tetrahidropiridotienopirimidina utiles para tratar o prevenir trastornos proliferativos celulares.
US20080021063A1 (en) * 2006-07-18 2008-01-24 Kazantsev Aleksey G Compositions and methods for modulating sirtuin activity
US7547781B2 (en) * 2006-09-11 2009-06-16 Curis, Inc. Quinazoline based EGFR inhibitors containing a zinc binding moiety
JP2010514810A (ja) * 2006-12-29 2010-05-06 ライジェル ファーマシューティカルズ, インコーポレイテッド Axlインヒビターとして有用な置換トリアゾール
NZ579877A (en) * 2007-04-20 2011-09-30 Glaxo Group Ltd Tricyclic nitrogen containing compounds as antibacterial agents
US20090105240A1 (en) 2007-10-17 2009-04-23 Tomas Mustelin Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
WO2009151569A2 (en) * 2008-06-09 2009-12-17 Combinatorx, Incorporated Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders
AU2010286168B2 (en) 2009-08-20 2014-05-15 Karus Therapeutics Limited Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
US20110178107A1 (en) 2010-01-20 2011-07-21 Taigen Biotechnology Co., Ltd. Hcv protease inhibitors
RU2451686C1 (ru) * 2010-12-27 2012-05-27 Александр Васильевич Иващенко ЗАМЕЩЕННЫЕ ГИДРИРОВАННЫЕ ТИЕНО-ПИРРОЛО [3,2-c] ПИРИДИНЫ, ЛИГАНДЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИХ ПРИМЕНЕНИЯ
WO2012131297A1 (en) 2011-03-28 2012-10-04 Jonathan Bayldon Baell Pyrido [3',2' :4,5] thieno [3, 2-d] pyrimidin- 4 - ylamine derivatives and their therapeutical use
US9056876B2 (en) 2011-09-16 2015-06-16 Vanderbilt University Substituted 1H-pyrazolo[3′,4′,4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
US20130116241A1 (en) 2011-11-09 2013-05-09 Abbvie Inc. Novel inhibitor compounds of phosphodiesterase type 10a
US9353121B2 (en) 2011-12-21 2016-05-31 The Regents Of The University Of Colorado, A Body Corporate Anti-cancer compounds targeting Ral GTPases and methods of using the same
US8697888B2 (en) * 2012-01-06 2014-04-15 Vanderbilt University Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
WO2013126856A1 (en) 2012-02-23 2013-08-29 Vanderbilt University Substituted 5-aminothieno[2,3-c]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4
HK1210696A1 (en) 2012-07-11 2016-05-06 Nimbus Iris, Inc. Irak inhibitors and uses thereof
US9056875B2 (en) * 2012-08-31 2015-06-16 Vanderbilt University Substituted pyrazolo[3′,4′:4,5]thieno[2,3-C]pyridazin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
WO2015027204A1 (en) 2013-08-23 2015-02-26 Vanderbilt University Substituted thieno[2,3-b]pyridine-2-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4
US9637498B2 (en) 2013-08-23 2017-05-02 Vanderbilt University Substituted thieno[2,3-C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
US9981920B2 (en) * 2014-06-26 2018-05-29 Rodin Therapeutics, Inc. Inhibitors of histone deacetylase
BR112018003417B1 (pt) 2016-06-22 2023-10-24 Vanderbilt University Composto modulador alostérico positivo do receptor muscarínico de acetilcolina m4 e composição farmacêutica que o compreende
US11008335B2 (en) * 2016-11-07 2021-05-18 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
US10927126B2 (en) * 2016-11-07 2021-02-23 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
CN109862893B (zh) 2016-11-07 2023-02-17 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
JP2021505581A (ja) * 2017-12-05 2021-02-18 ヴァンダービルト ユニヴァーシティ ムスカリン性アセチルコリンレセプターm4のポジティブアロステリック調節因子

Similar Documents

Publication Publication Date Title
RU2018142987A (ru) Положительные аллостерические модуляторы мускаринового ацетилхолинового рецептора m4
US10308614B2 (en) Therapeutic compounds and uses thereof
JP6229042B2 (ja) ビヘテロアリール化合物及びその使用
US9763922B2 (en) Therapeutic compounds and uses thereof
JP6435323B2 (ja) 炎症性障害の治療のための新規化合物及びその医薬組成物
JP2025026853A (ja) 縮合環化合物
KR101546167B1 (ko) 브루톤 티로신 키나아제의 억제제
US9284335B2 (en) Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines and/or [1,2,4]triazolo[1,5-c]pteridines for treatment of central nervous system diseases and disorders
JP2025535046A (ja) Kras g12c変異タンパク質の複素環阻害剤及びその使用
RU2014139601A (ru) Ингибиторы серин/треониновых киназ
RU2015152576A (ru) Производные индолин-2-она или пирролопиридин/пиримидин-2-она
JP2010510319A5 (enExample)
JP6914933B2 (ja) ヤヌスキナーゼ、並びにその組成物及びその使用
JP2016523911A5 (enExample)
CN101605540A (zh) 使用mek抑制剂的方法
RU2011107437A (ru) Ингибиторы кинуренин-3-моноксигеназы
EP2991977A1 (en) C-linked heterocycloalkyl substituted pyrimidines and their uses
JP6900491B2 (ja) ピラゾロピリミジン化合物及びその使用方法
JP2025540958A (ja) 蕁麻疹の治療のための野生型c-kitキナーゼ阻害剤としてのN-フェニル-ピラゾロ[1,5-A]ピリジン-3-カルボキサミド誘導体
JP7002335B2 (ja) Ddr1阻害剤としてのトリアザ-スピロデカノン
JP2017528515A5 (enExample)
CA2905530A1 (en) Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
JPWO2018097297A1 (ja) ピリド[3,4−d]ピリミジン誘導体及びその薬学的に許容される塩
RU2015144485A (ru) Геминально-замещенные цианоэтилпиразолопиридоны в качестве ингибиторов janus киназ
JP2019537581A5 (enExample)